Cargando…
In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours
Nanostructure lipid carriers (NLCs) were developed for the delivery of curmumin (CRN), a potent anticancer agent with low bioavailability, for the treatment of prostate cancer. NLCs prepared using high pressure homogenization (HPH) with around 150 nm particle size, − 40 V ζ-potential and excellent l...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315352/ https://www.ncbi.nlm.nih.gov/pubmed/34845679 http://dx.doi.org/10.1007/s13346-021-01095-1 |